Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02607813
Brief Title: Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations

First Submitted : November 5, 2015
First Submitted that Met QC Criteria : November 17, 2015
First Posted : November 18, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 16, 2019
Last Update Posted : July 17, 2019